The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 15, 2022

Filed:

Apr. 15, 2021
Applicant:

Sandoz Ag, Basel, CH;

Inventors:

Vivek Battu, Hyderabad, IN;

Akash Vijay Lingayat, Hyderabad, IN;

Amit Gupta, Hyderabad, IN;

Anandkrishna Laxmikant Kulkanri, Hyderabad, IN;

Assignee:

Sandoz AG, Basel, CH;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/20 (2006.01); A61K 33/08 (2006.01); A61K 31/506 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 9/2095 (2013.01); A61K 9/0053 (2013.01); A61K 9/2009 (2013.01); A61K 9/2018 (2013.01); A61K 9/2027 (2013.01); A61K 9/2054 (2013.01); A61K 9/2059 (2013.01); A61K 31/506 (2013.01); A61K 33/08 (2013.01);
Abstract

A pharmaceutical formulation is disclosed which includes at least: (1) elagolix sodium, (2) magnesium oxide, and (3) at least one disintegrating agent, such as crospovidone, croscarmellose sodium, sodium starch glycolate, pregelatinized and mixtures thereof. A tablet is also disclosed which includes a tablet core formed from the pharmaceutical formulation. The elagolix sodium tablets of the present disclosure display improved dissolution rates when tested using for example the Tablet Sink Time test. The tablets also exhibit improved storage stability of the elagolix sodium, with a reduction in degradation products during storage.


Find Patent Forward Citations

Loading…